We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+6.32%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$78.4B
AUM Growth
+$3.85B
(+5.2%)
Cap. Flow
-$180M
Cap. Flow
% of AUM
-0.23%
Top 10 Holdings %
Top 10 Hldgs %
13.07%
Holding
685
New
40
Increased
229
Reduced
367
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Polaris
PII
|
+$376M |
| 2 |
Wells Fargo
WFC
|
+$376M |
| 3 |
Qualcomm
QCOM
|
+$364M |
| 4 |
Centene
CNC
|
+$322M |
| 5 |
Gen Digital
GEN
|
+$302M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$399M |
| 2 |
Steel Dynamics
STLD
|
+$340M |
| 3 |
Bank of America
BAC
|
+$269M |
| 4 |
T-Mobile US
TMUS
|
+$255M |
| 5 |
MasTec
MTZ
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.27% |
| 2 | Industrials | 14.86% |
| 3 | Healthcare | 14.33% |
| 4 | Technology | 13.97% |
| 5 | Consumer Discretionary | 12.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Forward Air
FWRD
$579M
| $791K | ﹤0.01% |
8,814
-183
| -2% | -$16.9K |
|
|
IVC
577
DELISTED
Invacare Corporation
IVC
| $789K | ﹤0.01% |
97,746
-77,112
| -44% | -$642K |
|
|
NPTN
578
DELISTED
NEOPHOTONICS CORP
NPTN
| $784K | ﹤0.01% |
76,763
+6,413
| +9% | +$67.7K |
|
579
Arthur J. Gallagher & Co
AJG
$68.6B
| $776K | ﹤0.01% |
5,542
-778
| -12% | -$110K |
|
|
SIVB
580
DELISTED
SVB Financial Group
SIVB
| $775K | ﹤0.01% |
2,268
+222
| +11% | +$123K |
|
|
SEI
581
Solaris Energy Infrastructure
SEI
$3.31B
| $772K | ﹤0.01% |
79,237
+21,486
| +37% | +$228K |
|
|
CTO
582
CTO Realty Growth
CTO
$810M
| $771K | ﹤0.01% |
43,206
-27,975
| -39% | -$495K |
|
583
Avista
AVA
$3.17B
| $767K | ﹤0.01% |
17,964
-8,439
| -32% | -$387K |
|
|
ALE
584
DELISTED
Allete
ALE
| $766K | ﹤0.01% |
10,935
-7,654
| -41% | -$533K |
|
|
DHIL
585
DELISTED
Diamond Hill
DHIL
| $760K | ﹤0.01% |
+4,545
| New | +$778K |
|
|
ECHO
586
EchoStar
ECHO
$24.7B
| $750K | ﹤0.01% |
30,884
+3,045
| +11% | +$78.1K |
|
587
AerSale
ASLE
$269M
| $744K | ﹤0.01% |
59,723
-39,661
| -40% | -$485K |
|
588
Akamai
AKAM
$15.4B
| $742K | ﹤0.01% |
6,361
-4,284
| -40% | -$478K |
|
|
RDS.B
589
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $708K | ﹤0.01% |
18,239
| – | – |
|
590
Corpay
CPAY
$26.7B
| $707K | ﹤0.01% |
2,763
-62
| -2% | -$17.2K |
|
591
Exelon
EXC
$45.4B
| $706K | ﹤0.01% |
22,342
-25,398
| -53% | -$818K |
|
592
Vipshop
VIPS
$6.4B
| $691K | ﹤0.01% |
+34,390
| New | +$864K |
|
|
USAP
593
DELISTED
Universal Stainless & Alloy
USAP
| $683K | ﹤0.01% |
67,816
-45,173
| -40% | -$453K |
|
|
EEX
594
DELISTED
Emerald Holding
EEX
| $677K | ﹤0.01% |
125,589
-49,382
| -28% | -$265K |
|
|
MPT
595
Medical Properties Trust
MPT
$2.44B
| $676K | ﹤0.01% |
33,630
-715
| -2% | -$15.3K |
|
596
Graham Corp
GHM
$1.03B
| $672K | ﹤0.01% |
48,854
-1,044
| -2% | -$14.8K |
|
597
Academy Sports + Outdoors
ASO
$2.69B
| $668K | ﹤0.01% |
16,204
-62,870
| -80% | -$2.2M |
|
598
Vishay Precision Group
VPG
$852M
| $665K | ﹤0.01% |
19,526
-6,508
| -25% | -$216K |
|
599
Emergent Biosolutions
EBS
$304M
| $648K | ﹤0.01% |
+10,293
| New | +$661K |
|
600
FirstCash
FCFS
$9.57B
| $644K | ﹤0.01% |
+8,427
| New | +$638K |
|
Similar funds
Boston Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Boston Partners held 685 positions worth $78.4B, up 5.2% from $74.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Boston Partners's Q2 2021 filing shows 40 new, 229 increased, 367 reduced and 39 closed positions. Its largest new stake was Polaris: 2,775,896 shares worth $380M. The largest sale was Medtronic, an estimated $399M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Healthcare.
- Boston Partners's largest Q2 2021 buy was Polaris: 2,775,896 shares worth $380M.
- Boston Partners added most to Wells Fargo in Q2 2021, an estimated $376M increase.
- Boston Partners's biggest Q2 2021 reduction was Medtronic, cutting an estimated $399M.
- Boston Partners fully exited MasTec in Q2 2021, selling an estimated $204M.
- Boston Partners's ten largest holdings make up 13% of its $78.4B portfolio in Q2 2021.
- Boston Partners opened 40 new positions and closed 39 in Q2 2021.
- Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $78.4B.
Based on Boston Partners's 13F filing for Q2 2021, filed 12 Aug 2021.